2seventy bio Inc (TSVT)
4.76
-0.17
(-3.45%)
USD |
NASDAQ |
May 03, 16:00
4.76
0.00 (0.00%)
After-Hours: 20:00
2seventy bio Gross Profit Margin (Quarterly): 70.54% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 70.54% |
| September 30, 2023 | 58.79% |
| June 30, 2023 | 87.47% |
| March 31, 2023 | 89.68% |
| December 31, 2022 | 92.00% |
| September 30, 2022 | 70.46% |
| June 30, 2022 | 36.69% |
| Date | Value |
|---|---|
| March 31, 2022 | -9.49% |
| December 31, 2021 | 39.34% |
| September 30, 2021 | 98.34% |
| June 30, 2021 | -38.62% |
| March 31, 2021 | 85.68% |
| December 31, 2020 | 84.87% |
| September 30, 2020 | 92.85% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-38.62%
Minimum
Jun 2021
98.34%
Maximum
Sep 2021
61.33%
Average
77.71%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 75.29% |
| Johnson & Johnson | 69.55% |
| Regeneron Pharmaceuticals Inc | 84.95% |
| Macrogenics Inc | 98.22% |
| Akebia Therapeutics Inc | 66.79% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -66.29% |
| Return on Assets | -32.86% |
| Return on Invested Capital | -66.29% |
| Profit Margin (Quarterly) | -531.8% |
| Operating Margin (Quarterly) | -560.5% |
| Return on Net Operating Assets | -64.00% |